Acumen Pharmaceuticals, Inc. (ABOS) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$123.83M | -8.6% |
| 2024 | -$114.02M | -86.5% |
| 2023 | -$61.14M | -35.2% |
| 2022 | -$45.24M | -131.0% |
| 2021 | -$19.58M | -147.5% |
| 2020 | -$7.91M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$123.83M | -8.6% |
| 2024 | -$114.02M | -86.5% |
| 2023 | -$61.14M | -35.2% |
| 2022 | -$45.24M | -131.0% |
| 2021 | -$19.58M | -147.5% |
| 2020 | -$7.91M | — |